Literature DB >> 16457957

Lead inhibited N-methyl-D-aspartate receptor-independent long-term potentiation involved ryanodine-sensitive calcium stores in rat hippocampal area CA1.

X M Li1, Y Gu, J Q She, D M Zhu, Z D Niu, M Wang, J T Chen, L G Sun, D-Y Ruan.   

Abstract

Lead exposure is known to be associated with cognitive dysfunction in children. Impairment of the induction of long-term potentiation (LTP) has been reported in area CA1 of rat hippocampus following lead exposure in vivo and in vitro. The present study was carried out to investigate whether the alterations of N-methyl-d-aspartate (NMDA) receptor-independent LTP following lead exposure involve internal calcium stores in hippocampus CA1 synapses. Monosynaptic field excitatory postsynaptic potentials in hippocampal slice area CA1 were recorded using the whole-cell patch-clamp upon acute lead treatment, and these studies were coupled with calcium imaging experiments to observe internal calcium changes in cultured hippocampal neurons. Inhibiting calcium release by ryanodine significantly reduced NMDA receptor-independent LTP, and depletion of internal calcium stores with thapsigargin blocked this form of LTP. Caffeine, an agonist of ryanodine receptors, enhanced this form of LTP. However, caffeine-enhanced NMDA receptor-independent LTP was depressed after bath application of lead. Moreover, lead further decreased ryanodine- and thapsigargin-reduced NMDA receptor-independent LTP. Calcium imaging also confirmed that lead had an effect on internal calcium release and uptake. Taken together, these results demonstrated that lead inhibited NMDA receptor-independent LTP by action on calcium release and uptake by ryanodine-sensitive stores in rat hippocampal area CA1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16457957     DOI: 10.1016/j.neuroscience.2005.12.033

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.

Authors:  Robert E Hampson; Frances Miller; Guillermo Palchik; Sam A Deadwyler
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

Review 2.  Roles of somatic A-type K(+) channels in the synaptic plasticity of hippocampal neurons.

Authors:  Yoon-Sil Yang; Kyeong-Deok Kim; Su-Yong Eun; Sung-Cherl Jung
Journal:  Neurosci Bull       Date:  2014-02-13       Impact factor: 5.203

3.  Chronic caffeine treatment prevents stress-induced LTP impairment: the critical role of phosphorylated CaMKII and BDNF.

Authors:  K H Alzoubi; M Srivareerat; A M Aleisa; K A Alkadhi
Journal:  J Mol Neurosci       Date:  2012-06-16       Impact factor: 3.444

4.  Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717.

Authors:  R E Hampson; R A España; G A Rogers; L J Porrino; S A Deadwyler
Journal:  Psychopharmacology (Berl)       Date:  2008-11-05       Impact factor: 4.530

5.  Forced swimming stress increases natatory activity of lead-exposed mice.

Authors:  Ulisses C Araujo; Thomas E Krahe; Anderson Ribeiro-Carvalho; Regina A A Gomes; Bruna M Lotufo; Maria de Fátima R Moreira; Yael de Abreu-Villaça; Alex C Manhães; Cláudio C Filgueiras
Journal:  Toxicol Res       Date:  2020-06-05

6.  Development of the Adverse Outcome Pathway (AOP): Chronic binding of antagonist to N-methyl-d-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities of children.

Authors:  Magdalini Sachana; Alexandra Rolaki; Anna Bal-Price
Journal:  Toxicol Appl Pharmacol       Date:  2018-03-07       Impact factor: 4.219

7.  Influences of different developmental periods of taurine supplements on synaptic plasticity in hippocampal CA1 area of rats following prenatal and perinatal lead exposure.

Authors:  Shan-Shan Yu; Ming Wang; Xin-Mei Li; Wei-Heng Chen; Ju-Tao Chen; Hui-Li Wang; Di-Yun Ruan
Journal:  BMC Dev Biol       Date:  2007-05-19       Impact factor: 1.978

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.